| Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria GU Höglinger, G Respondek, M Stamelou, C Kurz, KA Josephs, AE Lang, ... Movement disorders 32 (6), 853-864, 2017 | 1717 | 2017 |
| Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease O Preische, SA Schultz, A Apel, J Kuhle, SA Kaeser, C Barro, S Gräber, ... Nature medicine 25 (2), 277-283, 2019 | 759 | 2019 |
| Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study BA Gordon, TM Blazey, Y Su, A Hari-Raj, A Dincer, S Flores, ... The Lancet Neurology 17 (3), 241-250, 2018 | 516 | 2018 |
| Hough-CNN: Deep learning for segmentation of deep brain regions in MRI and ultrasound F Milletari, SA Ahmadi, C Kroll, A Plate, V Rozanski, J Maiostre, J Levin, ... Computer Vision and Image Understanding 164, 92-102, 2017 | 453 | 2017 |
| A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease NR Barthélemy, Y Li, N Joseph-Mathurin, BA Gordon, J Hassenstab, ... Nature medicine 26 (3), 398-407, 2020 | 440 | 2020 |
| Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease J Wagner, S Ryazanov, A Leonov, J Levin, S Shi, F Schmidt, C Prix, ... Acta neuropathologica 125, 795-813, 2013 | 415 | 2013 |
| Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds M Caruana, T Högen, J Levin, A Hillmer, A Giese, N Vassallo FEBS letters 585 (8), 1113-1120, 2011 | 300 | 2011 |
| Single particle characterization of iron-induced pore-forming α-synuclein oligomers M Kostka, T Hogen, KM Danzer, J Levin, M Habeck, A Wirth, R Wagner, ... Journal of Biological Chemistry 283 (16), 10992-11003, 2008 | 286 | 2008 |
| The differential diagnosis and treatment of atypical parkinsonism J Levin, A Kurz, T Arzberger, A Giese, GU Höglinger Deutsches Ärzteblatt International 113 (5), 61, 2016 | 269 | 2016 |
| Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease E McDade, G Wang, BA Gordon, J Hassenstab, TLS Benzinger, V Buckles, ... Neurology 91 (14), e1295-e1306, 2018 | 259 | 2018 |
| Early changes in CSF sTREM2 in dominantly inherited Alzheimer’s disease occur after amyloid deposition and neuronal injury M Suárez-Calvet, MÁ Araque Caballero, G Kleinberger, RJ Bateman, ... Science translational medicine 8 (369), 369ra178-369ra178, 2016 | 254 | 2016 |
| Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study KM Moore, J Nicholas, M Grossman, CT McMillan, DJ Irwin, L Massimo, ... The Lancet Neurology 19 (2), 145-156, 2020 | 245 | 2020 |
| Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology M Suárez-Calvet, E Morenas-Rodríguez, G Kleinberger, K Schlepckow, ... Molecular neurodegeneration 14, 1-14, 2019 | 199 | 2019 |
| Extracellular vesicle sorting of α-Synuclein is regulated by sumoylation M Kunadt, K Eckermann, A Stuendl, J Gong, B Russo, K Strauss, S Rai, ... Acta neuropathologica 129, 695-713, 2015 | 194 | 2015 |
| First symptom in sporadic Creutzfeldt–Jakob disease GD Rabinovici, PN Wang, J Levin, L Cook, M Pravdin, J Davis, ... Neurology 66 (2), 286-287, 2006 | 178 | 2006 |
| Assessment of 18F-PI-2620 as a biomarker in progressive supranuclear palsy M Brendel, H Barthel, T van Eimeren, K Marek, L Beyer, M Song, C Palleis, ... JAMA neurology 77 (11), 1408-1419, 2020 | 172 | 2020 |
| Four-repeat tauopathies TW Roesler, AT Marvian, M Brendel, NP Nykaenen, M Hoellerhage, ... Progress in neurobiology 180, 101644, 2019 | 169 | 2019 |
| Which ante mortem clinical features predict progressive supranuclear palsy pathology? G Respondek, C Kurz, T Arzberger, Y Compta, E Englund, LW Ferguson, ... Movement Disorders 32 (7), 995-1005, 2017 | 159 | 2017 |
| Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study EL van der Ende, LH Meeter, JM Poos, JL Panman, LC Jiskoot, ... The Lancet Neurology 18 (12), 1103-1111, 2019 | 158 | 2019 |
| White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease MÁ Araque Caballero, M Suárez-Calvet, M Duering, N Franzmeier, ... Brain 141 (10), 3065-3080, 2018 | 142 | 2018 |
Armin GieseCSO, MODAG GmbH在 modag.net 的电子邮件经过验证
